Brief: LifeMD Q2 adjusted EPS USD 0.05
09/08/2023 22:48
Aug 9 (Reuters) - LifeMD Q2 adjusted EPS USD 0.05. * Q2 gross margin 87% * Q2 adjusted EBITDA USD 1.7 million * Q2 revenue USD 35.9 million vs. IBES estimate USD 35.2 million * Q2 net income USD -7.5 million * Outlook FY adjusted EBITDA USD 10-13 million
Recent news on LifeMD
See all newsLifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
Brief: LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million
LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons